| scholarly article | Q13442814 |
| P50 | author | Benjamin G Horst | Q56447641 |
| P2093 | author name string | Michael A Marletta | |
| P2860 | cites work | Crystal structures of the catalytic domain of human soluble guanylate cyclase | Q24336722 |
| On the activation of soluble guanylyl cyclase by nitric oxide. | Q24531355 | ||
| Ancient conserved domains shared by animal soluble guanylyl cyclases and bacterial signaling proteins | Q24798253 | ||
| Nitric oxide: physiology, pathophysiology, and pharmacology | Q26778243 | ||
| Unprecedented proximal binding of nitric oxide to heme: implications for guanylate cyclase | Q27627805 | ||
| NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism | Q27641107 | ||
| PAS-mediated Dimerization of Soluble Guanylyl Cyclase Revealed by Signal Transduction Histidine Kinase Domain Crystal Structure | Q27649070 | ||
| The crystal structure of the catalytic domain of a eukaryotic guanylate cyclase | Q27652454 | ||
| Crystal structure of the signaling helix coiled-coil domain of the β1 subunit of the soluble guanylyl cyclase | Q27659219 | ||
| Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase | Q27661554 | ||
| Crystal structure of the Alpha subunit PAS domain from soluble guanylyl cyclase | Q27679506 | ||
| Interfacial residues promote an optimal alignment of the catalytic center in human soluble guanylate cyclase: heterodimerization is required but not sufficient for activity | Q27682500 | ||
| Structural and Functional Evidence Indicates Selective Oxygen Signaling in Caldanaerobacter subterraneus H-NOX | Q27712655 | ||
| Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
| Identification of residues in the heme domain of soluble guanylyl cyclase that are important for basal and stimulated catalytic activity | Q28477878 | ||
| Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system | Q28513504 | ||
| The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine | Q29547539 | ||
| The Phyre2 web portal for protein modeling, prediction and analysis | Q29616136 | ||
| Control of nitric oxide dynamics by guanylate cyclase in its activated state. | Q30328713 | ||
| Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations | Q30449094 | ||
| Exquisite sensitivity to subsecond, picomolar nitric oxide transients conferred on cells by guanylyl cyclase-coupled receptors. | Q30497748 | ||
| Identification of novel S-nitrosation sites in soluble guanylyl cyclase, the nitric oxide receptor | Q30823314 | ||
| Sub-second kinetics of the nitric oxide receptor, soluble guanylyl cyclase, in intact cerebellar cells | Q31552489 | ||
| NO-independent regulatory site on soluble guanylate cyclase | Q32165040 | ||
| EPR characterization of axial bond in metal center of native and cobalt-substituted guanylate cyclase | Q33177632 | ||
| Endogenous nitric oxide synthesis: biological functions and pathophysiology | Q33814359 | ||
| Tissue distribution of the human soluble guanylate cyclases | Q33876232 | ||
| Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP | Q33948069 | ||
| Revisiting the kinetics of nitric oxide (NO) binding to soluble guanylate cyclase: the simple NO-binding model is incorrect | Q34155309 | ||
| Ligand-binding PAS domains in a genomic, cellular, and structural context | Q34191590 | ||
| Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase | Q34288133 | ||
| Structural insights into the role of iron-histidine bond cleavage in nitric oxide-induced activation of H-NOX gas sensor proteins | Q34407649 | ||
| Structure and signaling mechanism of Per-ARNT-Sim domains | Q35008317 | ||
| Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease | Q35010064 | ||
| Nitric oxide activation of guanylyl cyclase in cells revisited | Q35033233 | ||
| Motion of proximal histidine and structural allosteric transition in soluble guanylate cyclase | Q35378266 | ||
| Elevation of soluble guanylate cyclase suppresses proliferation and survival of human breast cancer cells | Q35558572 | ||
| Aspartate 102 in the heme domain of soluble guanylyl cyclase has a key role in NO activation | Q35855521 | ||
| Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation | Q35925811 | ||
| Heat Shock Protein 90 Associates with the Per-Arnt-Sim Domain of Heme-free Soluble Guanylate Cyclase: IMplications for Enzyme Maturation | Q36065122 | ||
| Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide | Q36466804 | ||
| Class III adenylyl cyclases: molecular mechanisms of catalysis and regulation | Q36512195 | ||
| Molecular model of a soluble guanylyl cyclase fragment determined by small-angle X-ray scattering and chemical cross-linking | Q36713981 | ||
| A molecular basis for nitric oxide sensing by soluble guanylate cyclase | Q36774286 | ||
| Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma | Q36865999 | ||
| Nucleotide regulation of soluble guanylate cyclase substrate specificity | Q37342409 | ||
| Mechanisms of activity-dependent plasticity in cellular nitric oxide-cGMP signaling | Q37377637 | ||
| A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase | Q37467778 | ||
| What is the real physiological NO concentration in vivo? | Q37551307 | ||
| YC-1 binding to the β subunit of soluble guanylyl cyclase overcomes allosteric inhibition by the α subunit. | Q37557818 | ||
| The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models | Q37563705 | ||
| Thiol-Based Redox Modulation of Soluble Guanylyl Cyclase, the Nitric Oxide Receptor | Q37588783 | ||
| Single-particle EM reveals the higher-order domain architecture of soluble guanylate cyclase | Q37612777 | ||
| Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia | Q37634112 | ||
| Nitric oxide signaling in brain function, dysfunction, and dementia. | Q37785420 | ||
| Structure and regulation of soluble guanylate cyclase | Q37992160 | ||
| The chemistry and biology of soluble guanylate cyclase stimulators and activators | Q38130465 | ||
| Soluble guanylyl cyclase: the nitric oxide receptor | Q38318731 | ||
| The opposing roles of NO and oxidative stress in cardiovascular disease. | Q38781378 | ||
| Structure and Activation of Soluble Guanylyl Cyclase, the Nitric Oxide Sensor | Q38894826 | ||
| Expression and characterization of the catalytic domains of soluble guanylate cyclase: interaction with the heme domain | Q39369792 | ||
| Mechanism of binding of NO to soluble guanylyl cyclase: implication for the second NO binding to the heme proximal site | Q39383344 | ||
| Picomolar nitric oxide signals from central neurons recorded using ultrasensitive detector cells. | Q39455068 | ||
| NO activation of guanylyl cyclase | Q40327686 | ||
| Allostery in recombinant soluble guanylyl cyclase from Manduca sexta | Q40642230 | ||
| Soluble guanylate cyclase is activated differently by excess NO and by YC-1: resonance Raman spectroscopic evidence | Q40978111 | ||
| Probing soluble guanylate cyclase activation by CO and YC-1 using resonance Raman spectroscopy | Q41563697 | ||
| Insight into the rescue of oxidized soluble guanylate cyclase by the activator cinaciguat | Q41770411 | ||
| Quaternary structure controls ligand dynamics in soluble guanylate cyclase | Q41971888 | ||
| The Influence of Nitric Oxide on Soluble Guanylate Cyclase Regulation by Nucleotides: ROLE OF THE PSEUDOSYMMETRIC SITE. | Q41998443 | ||
| Expression of nitric oxide synthase and soluble guanylyl cyclase in the developing olfactory system of Manduca sexta | Q42056433 | ||
| Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress. | Q42075795 | ||
| YC-1, a novel activator of platelet guanylate cyclase | Q42275468 | ||
| Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site? | Q42458596 | ||
| Differential sensitivity of guanylyl cyclase and mitochondrial respiration to nitric oxide measured using clamped concentrations. | Q44038804 | ||
| Kinetics of a cellular nitric oxide/cGMP/phosphodiesterase-5 pathway | Q44838264 | ||
| Spectroscopic characterization of the soluble guanylate cyclase-like heme domains from Vibrio cholerae and Thermoanaerobacter tengcongensis | Q45002543 | ||
| Femtomolar sensitivity of a NO sensor from Clostridium botulinum. | Q45096466 | ||
| Butyl isocyanide as a probe of the activation mechanism of soluble guanylate cyclase. Investigating the role of non-heme nitric oxide. | Q45953522 | ||
| Nitric Oxide-Induced Conformational Changes Govern H-NOX and Histidine Kinase Interaction and Regulation in Shewanella oneidensis. | Q46231509 | ||
| Role of the nucleotidyl cyclase helical domain in catalytically active dimer formation. | Q46271714 | ||
| Regulation of nitric oxide signaling by formation of a distal receptor-ligand complex | Q46297269 | ||
| Resonance Raman and infrared spectroscopic studies of high-output forms of human soluble guanylyl cyclase | Q46409117 | ||
| An enzyme-linked receptor mechanism for nitric oxide-activated guanylyl cyclase | Q46607492 | ||
| Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770. | Q46946599 | ||
| Discovery of stimulator binding to a conserved pocket in the heme domain of soluble guanylyl cyclase | Q47313531 | ||
| Heme-nitrosyls: electronic structure implications for function in biology. | Q53452625 | ||
| Measuring In Vivo Protein Half-Life | Q56169378 | ||
| Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate | Q68060992 | ||
| Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical | Q69908799 | ||
| Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide | Q70930193 | ||
| Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states | Q72677054 | ||
| Rate of deactivation of nitric oxide-stimulated soluble guanylate cyclase: influence of nitric oxide scavengers and calcium | Q73399151 | ||
| Localization of the heme binding region in soluble guanylate cyclase | Q73940521 | ||
| Identification of histidine 105 in the beta1 subunit of soluble guanylate cyclase as the heme proximal ligand | Q74378137 | ||
| Ligand selectivity of soluble guanylyl cyclase: effect of the hydrogen-bonding tyrosine in the distal heme pocket on binding of oxygen, nitric oxide, and carbon monoxide | Q79975136 | ||
| Functional characterization of two nucleotide-binding sites in soluble guanylate cyclase | Q83929538 | ||
| P304 | page(s) | 65-74 | |
| P577 | publication date | 2018-04-25 | |
| P1433 | published in | Nitric Oxide | Q7041392 |
| P1476 | title | Physiological activation and deactivation of soluble guanylate cyclase | |
| P478 | volume | 77 |
| Q83227485 | Allosteric activation of the nitric oxide receptor soluble guanylate cyclase mapped by cryo-electron microscopy |
| Q90673183 | Heart Failure With Preserved Ejection Fraction in Women: New Clues to Causes and Treatment |
| Q98196738 | The diversification and lineage-specific expansion of nitric oxide signaling in Placozoa: insights in the evolution of gaseous transmission |
| Q83227469 | Wedging open a catalytic site |
Search more.